Journals
Publish with us
Publishing partnerships
About us
Blog
International Scholarly Research Notices
Table of Contents
International Scholarly Research Notices
/
2013
/
Article
/
Tab 4
/
Clinical Study
Oxaliplatin and Bolus-Modulated 5-Fluorouracil as a Second-Line Treatment for Advanced Pancreatic Cancer: Can Bolus Regimens Replace FOLFOX When Considered for Second Line?
Table 4
Cost comparison of the 2 regimens.
ā
FLOX arm
3-week arm
value
Cost/patient/8 weeks
1200 USD
1400 USD
.013